Article
Inosine monophosphate dehydrogenase type 2 polymorphism IMPDH2 3757T>C (rs11706052) and 12-month evolution of the graft function in renal transplant recipients on mycophenolate-based immunosuppression.
The pharmacogenomics journal - 20 May 2024
Penezić Luka, Nađ-Škegro Sandra, Hadžavdić Ayla, Ganoci Lana, Kaštelan Željko, Trkulja Vladimir, Božina Nada
Abstract excerpt
Variant allele at the inosine monophosphate dehydrogenase type 2 polymorphism IMPDH2 3757T>C has been associated with increased enzyme activity and reduced susceptibility to mycophenolic acid (MPA) in vitro. It has been suggested associated with an increased risk of acute rejection in renal transplant recipients on MPA-based immunosuppression, but not unambiguously. We assessed one-year evolution of the estimated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
